To establish the role of NRP2 in tumour initiation more definitively, we injected TBP mice with a NRP2 inhibitory Ab (Anti-Nrp2B) at the time of pregnancy, which triggers tumour onset in this transgenic model. The gene discussed is NRP2; the disease is neoplasm.